Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer
About this study
The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.
- Condition
- Breast Cancer
- Tested
- Application of green indocyanine colorant, Technetium99
- Sponsor
- Omphis Foundation
Who can join
- Age
- 18 to 120 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 5
- Minimum age: 18 years
- Maximum age: 120 years
- Study condition: Breast Cancer
- Patients \>18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
- N0 patients or patients who have undergone target axillary detection with good response
Exclusion 1
- Lymphadenectomy
Where
1 site, 1 recruiting
Sandra Lopez Gordo
Cerdanyola del Vallès, Barcelona, Spain
Contact
-
Sandra Lopez gordo
0034660284047 sandra.lopezgordo@gmail.com
-
Sandra Lopez gordo
660284047 sandra.lopezgordo@gmail.com
Potential match only. Final eligibility is determined by the study team.